HIBA HAMMAD ALTAQ

• Board Eligible in Critical Care: Expected Certification 2024
• Board Certified in Pulmonology: Certification year 2023
• Board Certified in Internal Medicine: Certification year 2016
• ACLS/BLS

• 2023-2024 Chief Fellow – Pulmonary & Critical Care; University of Oklahoma
• 2023 CHEST Challenge 2nd Place
• 2023-2024 Medtronic Fellowship Academy - Optimizing Lung Cancer Care Through Education, Innovation, and Partnership
• 2024 Oklahoma Thoracic Society research award
• 2024 University of Oklahoma Gold Humanism Honor Society nominee
• 2020 Quest Care Outstanding Hospitalist Award
• 2015-2016 Chief Resident – Internal Medicine & Pediatrics; University of Buffalo
• 2011-2012 Ross University Dean List award
• 2008-2009 University of Miami Academic Honors Award
• 2008-2009 University of Miami Summa cum laude graduate

• American College of Chest Physicians
• American Thoracic Society

Hammad, H.  (Principle Investigator ), Kebbe ,J (Co-Investigator) , "CSL787," A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy, Safety, and Tolerability of CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis. 

Sponsored by CSL Behring

Hammad, H . (Co-Investigator), Metcalf  (Principal Investigator). "MEDI3506" . A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA).

Sponsored by AstraZeneca study

Hammad, H.(Co- Investigator),Youness, H (Principal Investigator). "Biotest 996 ESsCAPE" A randomized, placebo-controlled, double-blind, multi-center, phase III trial to assess the efficacy and safety of trimodulin (BT588) in adult hospitalized subjects with severe community-acquired pneumonia (sCAP).

Sepetember , present

• Hammad Altaq H, Parmar M, Syed Hussain T, Salim DJ, Chaudry FA, The Use of Robotic-Assisted Bronchoscopy in the Diagnostic Evaluation of Peripheral Pulmonary Lesions: A Paradigm Shift, Diagnostics (Basel), 03/09/2023.36980358, PMC10046947
• Hammad Altaq, H.;Kamath, S.; Abdo, T. Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades? Microorganisms .2023, 11, 2231. https://doi.org/10.3390 /microorganisms11092231 Ramji HF, Hafiz M, Altaq HH, Hussain ST, Chaudry F. Acute Respiratory Distress Syndrome; A Review of Recent Updates and a Glance into the Future, Diagnostics (Basel), 04/24/2023. 37174920, PMC10177247
• Hammad, Hiba .Sarkar, Malancha . Subbarayan, Pochi and Ardalan, Bach. (2012). Thymidylate Synthase 5' UTR Polymorphic Allele Distribution in South Florida Population. Journal of Cancer Therapy. 03. 10.4236/jct.2012.32024.
• Hammad, Hiba . Sarkar, Malancha. Gupta, Nikhil. Ardalan, Bach and Subbarayan, Pochi. (2011). The presence of three repeats in the 5 ' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA expression in cultured human cancer cell lines in vitro. Oncology reports. 27. 246-9. 10.3892/or.2011.1469